Kurbanova A.B.

2 ta ish

TMA Tashkent, Uzbekistan

1. DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS

   Najmutdinova D.K, Kurbanova A.B.

   BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.876704

2. DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS

   Najmutdinova D.K, Kurbanova A.B.

   BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.876832